Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes Who Require Nutritional Support
NCT06632002 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103
Last updated 2026-03-09
Summary
The study aims to demonstrate the non-inferiority of diabetes-specific formula (DSF)1 compared to DSF2 in individuals with type 1 diabetes, type 2 diabetes or prediabetes and who are at nutritional risk.
Conditions
Interventions
- OTHER
-
DSF1
220 mL
- OTHER
-
DSF2
220 mL
- OTHER
-
Standard of Care (SOC)
Standard of care
Sponsors & Collaborators
-
Abbott Nutrition
lead INDUSTRY
Principal Investigators
-
Mandy Yen Ling Ow, PhD · Abbott Nutrition
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-02
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Glycemic Response in Adults With Type 2 Diabetes
NCT05166200 ·Status: COMPLETED ·Phase: NA
-
Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes
NCT01188200 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Nutritional Product for People With Type 2 Diabetes
NCT01850810 ·Status: COMPLETED ·Phase: NA
-
Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas
NCT00540488 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone.
NCT02538640 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Products in Subjects With Type 2 Diabetes
NCT02923960 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Glycemic Response in Individuals With Type 2 Diabetes
NCT05165693 ·Status: COMPLETED ·Phase: NA
-
Stem Cells From Human Exfoliated Teeth in Treatment of Type 2 Diabetes
NCT03658655 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus
NCT02898766 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.
NCT01850134 ·Status: WITHDRAWN ·Phase: NA
-
Postprandial Glycemic Response in Adults With Type 2 Diabetes
NCT05154045 ·Status: COMPLETED ·Phase: NA
-
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
NCT00753181 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Nutritional Products for People With Type 2 Diabetes
NCT00797069 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention Effects of Optimized Carbohydrate Diet in Patients With Type 2 Diabetes
NCT06936657 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients
NCT06645002 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Diabetes-Specific Nutritional Formulas Versus Oatmeal
NCT02691481 ·Status: COMPLETED ·Phase: NA
-
Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.
NCT02538653 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus
NCT03176056 ·Status: COMPLETED ·Phase: NA
-
Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes
NCT02256332 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Glycemic Responses to Nutritional Products
NCT05179031 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics
NCT01324921 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of a Carbohydrate Drink in Adults
NCT04313920 ·Status: COMPLETED ·Phase: NA
-
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
NCT02132442 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Carbohydrates - Glycemic Index
NCT03508154 ·Status: COMPLETED ·Phase: NA
-
Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin
NCT01039662 ·Status: COMPLETED ·Phase: NA